… reductions: SGRQ score change of 4 points and FEV 1 change of 100 mL. The thresholds
for clinically important relative risk reductions … important absolute risk reductions were based …

… Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease: the COPE study. Am J Respir Crit Care Med. 2002;166:1358–1363. …

… This was an observational comparative effectiveness study aimed to evaluate the effect of
inhaled corticosteroid (ICS) cessation versus continuation of triple therapy in COPD patients. …

… of corticosteroid prescriptions within 1 year after discharge in the ICS withdrawal group. …
infection, our findings suggest that ICS withdrawal may also reduce mild-to-moderate COPD …

… effect of prior therapy, in particular inhaled corticosteroid (ICS) withdrawal, on study results.
… due to an ICS withdrawal effect. We did see a dampening of the reduction in moderate and …

… fixed combination inhaled corticosteroids (ICS) and long-acting β-agonists by symptomatic
patients with chronic obstructive pulmonary disease (COPD) who experience, or are at risk of, …

… for discontinuing inhaled corticosteroids. Providers reported reluctance to discontinue
inhaled corticosteroids; even in cases they would otherwise discontinue inhaled corticosteroids. …

… Since ICS, particularly in combination with a LABA, can reduce the risk of severe asthma …
maintenance therapy may result in substantial withdrawal during such a study due to …

… the rationale for withdrawal from inhaled corticosteroids (ICSs… risk reduction that increased
from 20.0% by the first month to 50.0% by the fourth month, and then stabilized. Risk reduction …

… the association between ICS withdrawal and the rate of FEV 1 … model the association between
ICS withdrawal and the rate of … Effects of withdrawal of inhaled steroids in men with severe …